Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report.

Shintaro SatoK AkasakaH OhtaY TsukaharaG KidaE TsumiyamaK KusanoT ObaT NishizawaR KawabeH YamakawaM AmanoH MatsushimaT Takada

Published in: BMC pulmonary medicine (2020)

PAP should be considered as one of the differential diseases when the newly interstitial shadow was observed during immunosuppressive treatment. WLL should be regarded as the treatment option for APAP concurred in connective tissue disease (CTD).

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
pulmonary hypertension
drug induced